The Pharmaceutical Expenditure Growth and Global Budget System under National Health Insurance

碩士 === 開南大學 === 商學院碩士在職專班 === 102 === NHI in Taiwan, has been the guardian of the public health insurance system and its also praised by other countries, beginning in 1996 the implementation of the NHI, which has been facing financial difficulties challenge, where drugs expenditure accounted for 25%...

Full description

Bibliographic Details
Main Authors: I-Cheng Cho, 卓益誠
Other Authors: Jen-Te Hwang
Format: Others
Language:zh-TW
Published: 2013
Online Access:http://ndltd.ncl.edu.tw/handle/27045743366573894694
Description
Summary:碩士 === 開南大學 === 商學院碩士在職專班 === 102 === NHI in Taiwan, has been the guardian of the public health insurance system and its also praised by other countries, beginning in 1996 the implementation of the NHI, which has been facing financial difficulties challenge, where drugs expenditure accounted for 25% of total health expenditure amounted to drug costs keep rising, the Central Health Insurance Department has implemented 7 times drug price survey and adjustment, narrowing the drug prices gap between the actual, since 1996, the drugs expenditure decreased from 30% to 15%,lowered about NT:420 billions. In this study, the use of drugs reported amounts of NHI drug price changes of data collection yearly, the main cause of the increase drugs expenditure, that cause health care spending has increased aging of the population, a new drug payment, and significant increase in the number of injuries, are the main cause of high drug costs. According to this study made the following recommendations: NHI drug price survey should be regularly drug spreads to narrow, the implementation of drugs expenditure targeting and drug copayment policy. let NHI sustainable for all people to seek medical treatment can not affect.